- The report contains detailed information about Haemonetics Corp. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Haemonetics Corp.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Haemonetics Corp. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Haemonetics Corp. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Haemonetics Corp. business.
About Haemonetics Corp.
Haemonetics Corporation provides blood management solutions primarily in the United States, Europe, and Asia. The company also offers devices and related consumables, information technology platforms, and consulting services. Its product portfolio helps hospitals determine blood demand and individual patient treatments. The companys principal operations are in the United States, Europe, and Japan.
Products and Solutions
The company markets a suite of products, including devices and consumables, information technology platforms, and consulting services for plasma collectors, blood collectors, and hospitals to manage blood supply and demand. It develops and markets various systems used with plasma and blood donors to automate the collection and processing of blood into its components: plasma, platelets, and red cells. The company also develops and markets various systems to hospitals that automate the cleaning and reinfusion of a surgical patients blood during surgery, automate the tracking and distribution of blood in the hospital, and improve blood diagnostics. It also markets information technology platforms to promote compliant operations for its customer groups. It markets consulting services to support best practices in blood management. The company's product lines include plasma, blood bank, hospital, and software solutions.
Automated Plasma Collection Systems
The company offers a range of products necessary for their plasma collection operations to its plasma collection customers. In addition to marketing its PCS brand plasma collection equipment and consumables, the company offers plasma collection containers, intravenous solutions, and tubing sealers necessary for plasma collection and storage. It has introduced an Express protocol for its PCS system that speeds up the donation process, allowing its customers to improve device utilization.
The company also offers a portfolio of information technology platforms for plasma customers to manage their donors, operations, and supply chain. eQue Automated Interview and Assessment automates the donor interview and qualification process. eLynx Workflow Optimization streamlines the workflow process in the plasma center. DMS Donor Management System provides plasma collection centers with the controls necessary to continually assess and evaluate donor suitability, determine the release-ability of units collected, and manage unit distribution. The Cash Payment System (CaPS) is an e-commerce application that provides cash dispensation and control for plasma collection centers which pay a fee to their donors. LOGIC is an integrated solution for the warehousing and disposition of plasma products. With its information technology platforms, plasma collectors are better able to manage processes across the plasma supply chain and react to business dynamics.
For consulting services, the company offers customers business solutions to support process excellence, donor recruitment, and business design. The company markets its PCS systems and software solutions to commercial plasma collectors, as well as to not-for-profit blood banks and government affiliated plasma collectors worldwide.
Automated Blood Collection Systems
The company's automated blood collection systems are used to separate and collect plasma, platelets, and red blood cells at the point of blood collection. It markets the MCS brand system for the automation of platelet collection, including improved platelet yields and patient safety. The companys MCS brand system is an apheresis system meaning that it has specific blood component collection objectives, returns to the donor the unwanted blood components, and replaces the volume of fluids collected with a saline return benefiting the donor. The companys automated platelet collection systems collect one or more therapeutic doses of platelets during a single donation by a volunteer blood donor.
Red cells are frequently transfused to patients to replace blood lost during surgery. Automated red cell collection, a technology the company created, allows for the collection of various red cells from a single donor than are collected in a manual, wh
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. HAEMONETICS CORP. COMPANY PROFILE
1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. HAEMONETICS CORP. BUSINESS OVERVIEW
2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. HAEMONETICS CORP. SWOT ANALYSIS
4. HAEMONETICS CORP. FINANCIAL ANALYSIS
4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. HAEMONETICS CORP. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Haemonetics Corp. Direct Competitors
5.2. Comparison of Haemonetics Corp. and Direct Competitors Financial Ratios
5.3. Comparison of Haemonetics Corp. and Direct Competitors Stock Charts
5.4. Haemonetics Corp. Industry Analysis
5.4.1. Healthcare Equipment/Supplies Industry Snapshot
5.4.2. Haemonetics Corp. Industry Position Analysis
6. HAEMONETICS CORP. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. HAEMONETICS CORP. EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. HAEMONETICS CORP. ENHANCED SWOT ANALYSIS2
9. UNITED STATES PESTEL ANALYSIS2
9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. HAEMONETICS CORP. IFE, EFE, IE MATRICES2
10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. HAEMONETICS CORP. PORTER FIVE FORCES ANALYSIS2
12. HAEMONETICS CORP. VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Haemonetics Corp. Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Haemonetics Corp. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Haemonetics Corp. Major Shareholders
Haemonetics Corp. History
Haemonetics Corp. Products
Revenues by Segment
Revenues by Region
Haemonetics Corp. Offices and Representations
Haemonetics Corp. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Haemonetics Corp. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Haemonetics Corp. Capital Market Snapshot
Haemonetics Corp. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Equipment/Supplies Industry Statistics
Haemonetics Corp. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Haemonetics Corp. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Haemonetics Corp. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Haemonetics Corp. 1-year Stock Charts
Haemonetics Corp. 5-year Stock Charts
Haemonetics Corp. vs. Main Indexes 1-year Stock Chart
Haemonetics Corp. vs. Direct Competitors 1-year Stock Charts
Haemonetics Corp. Article Density Chart
1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
SWOT, which stands for Strengths, Weaknesses, Opportunities and Threats, is an analytical framework that identifies the internal and external factors that are favorable and unfavorable for a company.
Enhanced SWOT Analysis
Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Upon answering these questions a company can develop a project plan to improve its business performance.
PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.
Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.
Key Factors Examined by PESTEL Analysis:
- Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
- Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
- Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
- Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
- Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.
The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.
The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.
Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.
Porter Five Forces Analysis
The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:
- Costly to imitate?
- Organized properly?